Tyk2 inhibitors and uses thereof

Abstract

Described herein are compounds that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.

Description

CROSS-REFERENCE

[0001] This patent application claims the benefit of US Provisional Application No. 62 / 749,003, filed October 22, 2018; US Provisional Application No. 62 / 756,942, filed November 7, 2018; US Provisional Application No. 62 / 839,459, filed April 26, 2019; US Provisional Application No. 62 / 875,449, filed July 17, 2019; US Provisional Application No. 62 / 893,721, filed August 29, 2019; and US Provisional Application No. 62 / 907,354, filed September 27, 2019 each of which is incorporated herein by reference in their entirety.FIELD OF THE INVENTION

[0002] Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds for inhibiting nonreceptor tyrosine-protein kinase 2 ("TYK2"), also known as Tyrosine kinase 2.BACKGROUND OF THE INVENTION

[0003] TYK2 is a non-receptor tyrosine kinase member of the Janus kinase (JAKs) family of protein kinases. The mammalian JAK family consists of four members, TYK2, JAK1, JAK2, and JAK3. JAK proteins, including TYK2, are integral to cytokine signaling. TYK2 associates with the cytoplasmic domain of type 1 and type II cytokine receptors, as well as interferon types I and III receptors, and is activated by those receptors upon cytokine binding. Cytokines implicated in TYK2 activation include interferons (e.g. IFN-α, IFN-β, IFN-κ, IFN-δ, IFN-ε, IFN-τ, IFN-ω, and IFN-ζ (also known as limitin), and interleukins (e.g. IL-4, IL-6, IL-10, IL-11, IL-12, IL-13, L-22, IL-23, IL-27, IL-31, oncostatin M, ciliary neurotrophic factor, cardiotrophin 1, cardiotrophin-like cytokine, and L1F). The activated TYK2 then goes on to phosphorylate further signaling proteins such as members of the STAT family, including STAT1, STAT2, STAT4, and STAT6.

[0004] TYK2 activation by IL-23, has been linked to inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. A genome-wide association study of 2,622 individuals with psoriasis identified associations between disease susceptibility and TYK2. Knockout or tyrphostin inhibition of TYK2 significantly reduces both IL-23 and IL-22-induced dermatitis.

[0005] TYK2 also plays a role in respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and cystic fibrosis. Goblet cell hyperplasia (GCH) and mucous hypersecretion is mediated by IL-13-induced activation of TYK2, which in turn activates STAT6.

[0006] Decreased TYK2 activity leads to protection of joints from collagen antibody-induced arthritis, a model of human rheumatoid arthritis. Mechanistically, decreased Tyk2 activity reduced the production of Th1 / Th17-related cytokines and matrix metalloproteases, and other key markers of inflammation.

[0007] TYK2 knockout mice showed complete resistance in experimental autoimmune encephalomyelitis (EAE, an animal model of multiple sclerosis (MS)), with no infiltration of CD4 T cells in the spinal cord, as compared to controls, suggesting that TYK2 is essential to pathogenic CD4-mediated disease development in MS. This corroborates earlier studies linking increased TYK2 expression with MS susceptibility. Loss of function mutation in TYK2, leads to decreased demyelination and increased remyelination of neurons, further suggesting a role for TYK2 inhibitors in the treatment of MS and other CNS demyelination disorders.

[0008] TYK2 is the sole signaling messenger common to both IL-12 and IL-23. TYK2 knockout reduced methylated BSA injection-induced footpad thickness, imiquimod-induced psoriasis-like skin inflammation, and dextran sulfate sodium or 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.

[0009] Joint linkage and association studies of various type 1 IFN signaling genes with systemic lupus erythematosus (SLE, an autoimmune disorder), showed a strong, and significant correlation between loss of function mutations to TYK2 and decreased prevalence of SLE in families with affected members. Genome-wide association studies of individuals with SLE versus an unaffected cohort showed highly significant correlation between the TYK2 locus and SLE.

[0010] TYK2 has been shown to play an important role in maintaining tumor surveillance and TYK2 knockout mice showed compromised cytotoxic T cell response, and accelerated tumor development. However, these effects were linked to the efficient suppression of natural killer (NK) and cytotoxic T lymphocytes, suggesting that TYK2 inhibitors would be highly suitable for the treatment of autoimmune disorders or transplant rejection. Although other JAK family members such as JAK3 have similar roles in the immune system, TYK2 has been suggested as a superior target because of its involvement in fewer and more closely related signaling pathways, leading to fewer off-target effects.

[0011] Studies in T-cell acute lymphoblastic leukemia (T-ALL) indicate that T-ALL is highly dependent on IL-10 via TYK2 via STAT1-mediated signal transduction to maintain cancer cell survival through upregulation of anti-apoptotic protein BCL2. Knockdown of TYK2, but not other JAK family members, reduced cell growth. Specific activating mutations to TYK2 that promote cancer cell survival include those to the FERM domain (G36D, S47N, and R425H), the JH2 domain (V73 11), and the kinase domain (E957D and R1027H). However, it was also identified that the kinase function of TYK2 is required for increased cancer cell survival, as TYK2 enzymes featuring kinase-dead mutations (M978Y or M978F) in addition to an activating mutation (E957D) resulted in failure to transform.

[0012] Thus, selective inhibition of TYK2 has been suggested as a suitable target for patients with IL-10 and / or BCL2-addicted tumors, such as 70% of adult T-cell leukemia cases. TYK2 mediated STAT3 signaling has also been shown to mediate neuronal cell death caused by amyloid-β (Aβ) peptide. Decreased TYK2 phosphorylation of STAT3 following Aβ administration lead to decreased neuronal cell death, and increased phosphorylation of STAT3 has been observed in postmortem brains of Alzheimer's patients.

[0013] Inhibition of JAK-STAT signaling pathways is also implicated in hair growth, and the reversal of the hair loss associated with alopecia areata.

[0014] Accordingly, compounds that inhibit the activity of TYK2 are beneficial, especially those with selectivity over JAK2. Such compounds should deliver a pharmacological response that favorably treats one or more of the conditions described herein without the side-effects associated with the inhibition of JAK2.

[0015] Accordingly there is a need to provide novel inhibitors having more effective or advantageous pharmaceutically relevant properties, like selectivity over other JAK kinases (especially JAK2).BRIEF SUMMARY OF THE INVENTION

[0016] Disclosed herein is a compound of Formula (XII), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more RA. each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; or -L-Ring A is absent; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, orC 1 -C 6 haloalkyl; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0017] Also disclosed herein is a compound of Formula (XIII), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; or -L-Ring A is absent; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< . -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=O)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, orC 1 -C 6 haloalkyl; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0018] Also disclosed herein is a pharmaceutical composition comprising a therapeutically effective amount of the compound disclosed herein, or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof, and a pharmaceutically acceptable excipient.

[0019] Also disclosed herein is a method of inhibiting a TYK2 enzyme in a patient or biological sample comprising contacting said patient or biological sample with a compound disclosed herein, or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof.

[0020] Also disclosed herein is a method of treating a TYK2-mediated disorder comprising administering to a patient in need thereof a compound disclosed herein, or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation. In some embodiments, the disorder is associated with type I interferon, IL-10, IL-12, or IL-23 signaling.INCORPORATION BY REFERENCE

[0021] All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference for the specific purposes identified herein.DETAILED DESCRIPTION OF THE INVENTION Definitions

[0022] As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an agent" includes a plurality of such agents, and reference to "the cell" includes reference to one or more cells (or to a plurality of cells) and equivalents thereof known to those skilled in the art, and so forth. When ranges are used herein for physical properties, such as molecular weight, or chemical properties, such as chemical formulae, all combinations and subcombinations of ranges and specific embodiments therein are intended to be included. The term "about" when referring to a number or a numerical range means that the number or numerical range referred to is an approximation within experimental variability (or within statistical experimental error), and thus the number or numerical range, in some instances, will vary between 1% and 15% of the stated number or numerical range. The term "comprising" (and related terms such as "comprise" or "comprises" or "having" or "including") is not intended to exclude that in other certain embodiments, for example, an embodiment of any composition of matter, composition, method, or process, or the like, described herein, "consist of" or "consist essentially of" the described features.

[0023] As used in the specification and appended claims, unless specified to the contrary, the following terms have the meaning indicated below.

[0024] "Aliphatic chain" refers to a linear chemical moiety that is composed of only carbons and hydrogens. In some embodiments, the aliphatic chain is saturated. In some embodiments, the aliphatic chain is unsaturated. In some embodiments, the unsaturated aliphatic chain contains one unsaturation. In some embodiments, the unsaturated aliphatic chain contains more than one unsaturation. In some embodiments, the unsaturated aliphatic chain contains two unsaturations. In some embodiments, the unsaturated aliphatic chain contains one double bond. In some embodiments, the unsaturated aliphatic chain contains two double bonds.

[0025] "Alkyl" refers to an optionally substituted straight-chain, or optionally substituted branched-chain saturated hydrocarbon monoradical having from one to about ten carbon atoms, or from one to six carbon atoms. Examples include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, 2-methyl-1-propyl, 2-methyl-2-propyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-3-butyl, 2,2-dimethyl-1-propyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2,2-dimethyl-1-butyl, 3,3-dimethyl-1-butyl, 2-ethyl-1-butyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, tert-amyl and hexyl, and longer alkyl groups, such as heptyl, octyl, and the like. Whenever it appears herein, a numerical range such as "C 1 -C 6 alkyl" means that the alkyl group consists of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term "alkyl" where no numerical range is designated. In some embodiments, the alkyl is a C 1 -C 10 alkyl, a C 1 -C 9 alkyl, a C 1 -C 8 alkyl, a C 1 -C 7 alkyl, a C 1 -C 6 alkyl, a C 1 -C 5 alkyl, a C 1 -C 4 alkyl, a C 1 -C 3 alkyl, a C 1 -C 2 alkyl, or a C 1 alkyl. Unless stated otherwise specifically in the specification, an alkyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkyl is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, the alkyl is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the alkyl is optionally substituted with halogen.

[0026] "Alkenyl" refers to an optionally substituted straight-chain, or optionally substituted branched-chain hydrocarbon monoradical having one or more carbon-carbon double-bonds and having from two to about ten carbon atoms, more preferably two to about six carbon atoms. The group may be in either the cis or trans conformation about the double bond(s), and should be understood to include both isomers. Examples include, but are not limited to, ethenyl (-CH=CH 2 ), 1-propenyl (-CH 2 CH=CH 2 ), isopropenyl [-C(CH 3 )=CH 2 ], butenyl, 1,3-butadienyl and the like. Whenever it appears herein, a numerical range such as "C 2 -C 6 alkenyl" means that the alkenyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term "alkenyl" where no numerical range is designated. In some embodiments, the alkenyl is a C 2 -C 10 alkenyl, a C 2 -C 9 alkenyl, a C 2 -C 8 alkenyl, a C 2 -C 7 alkenyl, a C 2 -C 6 alkenyl, a C 2 -C 5 alkenyl, a C 2 -C 4 alkenyl, a C 2 -C 3 alkenyl, or a C 2 alkenyl. Unless stated otherwise specifically in the specification, an alkenyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, an alkenyl is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the alkenyl is optionally substituted with halogen.

[0027] "Alkynyl" refers to an optionally substituted straight-chain or optionally substituted branched-chain hydrocarbon monoradical having one or more carbon-carbon triple-bonds and having from two to about ten carbon atoms, more preferably from two to about six carbon atoms. Examples include, but are not limited to, ethynyl, 2-propynyl, 2-butynyl, 1,3-butadiynyl and the like. Whenever it appears herein, a numerical range such as "C 2 -C 6 alkynyl" means that the alkynyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term "alkynyl" where no numerical range is designated. In some embodiments, the alkynyl is a C 2 -C 10 alkynyl, a C 2 -C 9 alkynyl, a C 2 -C 8 alkynyl, a C 2 -C 7 alkynyl, a C 2 -C 6 alkynyl, a C 2 -C 5 alkynyl, a C 2 -C 4 alkynyl, a C 2 -C 3 alkynyl, or a C 2 alkynyl. Unless stated otherwise specifically in the specification, an alkynyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, -CN, - CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, an alkynyl is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the alkynyl is optionally substituted with halogen.

[0028] "Alkylene" refers to a straight or branched divalent hydrocarbon chain. Unless stated otherwise specifically in the specification, an alkylene group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, an alkylene is optionally substituted with oxo, halogen, - CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, an alkylene is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the alkylene is optionally substituted with halogen.

[0029] "Alkoxy" refers to a radical of the formula -OR a where R a is an alkyl radical as defined. Unless stated otherwise specifically in the specification, an alkoxy group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, an alkoxy is optionally substituted with oxo, halogen, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the alkoxy is optionally substituted with halogen.

[0030] "Aminoalkyl" refers to an alkyl radical, as defined above, that is substituted by one or more amines. In some embodiments, the alkyl is substituted with one amine. In some embodiments, the alkyl is substituted with one, two, or three amines. Hydroxyalkyl include, for example, aminomethyl, aminoethyl, aminopropyl, aminobutyl, or aminopentyl. In some embodiments, the hydroxyalkyl is aminomethyl.

[0031] "Aryl" refers to a radical derived from a hydrocarbon ring system comprising hydrogen, 6 to 30 carbon atoms and at least one aromatic ring. The aryl radical may be a monocyclic, bicyclic, tricyclic or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocycloalkyl ring, the aryl is bonded through an aromatic ring atom) or bridged ring systems. In some embodiments, the aryl is a 6- to 10-membered aryl. In some embodiments, the aryl is a 6-membered aryl. Aryl radicals include, but are not limited to, aryl radicals derived from the hydrocarbon ring systems of anthrylene, naphthylene, phenanthrylene, anthracene, azulene, benzene, chrysene, fluoranthene, fluorene, as-indacene, s-indacene, indane, indene, naphthalene, phenalene, phenanthrene, pleiadene, pyrene, and triphenylene. In some embodiments, the aryl is phenyl. Unless stated otherwise specifically in the specification, an aryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, -CN, - CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the aryl is optionally substituted with halogen.

[0032] "Cycloalkyl" refers to a stable, partially or fully saturated, monocyclic or polycyclic carbocyclic ring, which may include fused (when fused with an aryl or a heteroaryl ring, the cycloalkyl is bonded through a non-aromatic ring atom) or bridged ring systems . Representative cycloalkyls include, but are not limited to, cycloalkyls having from three to fifteen carbon atoms (C 3 -C 15 cycloalkyl), from three to ten carbon atoms (C 3 -C 10 cycloalkyl), from three to eight carbon atoms (C 3 -C 8 cycloalkyl), from three to six carbon atoms (C 3 -C 6 cycloalkyl), from three to five carbon atoms (C 3 -C 5 cycloalkyl), or three to four carbon atoms (C 3 -C 4 cycloalkyl). In some embodiments, the cycloalkyl is a 3- to 6-membered cycloalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered cycloalkyl. Monocyclic cycloalkyls include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Polycyclic cycloalkyls or carbocycles include, for example, adamantyl, norbornyl, decalinyl, bicyclo[3.3.0]octane, bicyclo[4.3 .0]nonane, cis-decalin, trans-decalin, bicyclo[2.1.1]hexane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, and bicyclo[3.3.2]decane, and 7,7-dimethyl-bicyclo[2.2.1]heptanyl. Partially saturated cycloalkyls include, for example cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. Unless stated otherwise specifically in the specification, a cycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, - CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the cycloalkyl is optionally substituted with halogen.

[0033] "Deuteroalkyl" refers to an alkyl radical, as defined above, that is substituted by one or more deuterium atoms. In some embodiments, the alkyl is substituted with one deuterium atom. In some embodiments, the alkyl is substituted with one, two, or three deuterium atoms. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six deuterium atomss. Deuteroalkyl includes, for example, CD 3 , CH 2 D, CHD 2 , CH 2 CD 3 , CD 2 CD 3 , CHDCD 3 , CH 2 CH 2 D, or CH 2 CHD 2 . In some embodiments, the deuteroalkyl is CD 3 .

[0034] "Haloalkyl" refers to an alkyl radical, as defined above, that is substituted by one or more halogen atoms. In some embodiments, the alkyl is substituted with one, two, or three halogen atoms. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six halogen halogens. Haloalkyl includes, for example, trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 1,2-difluoroethyl, 3-bromo-2-fluoropropyl, 1,2-dibromoethyl, and the like. In some embodiments, the haloalkyl is trifluoromethyl.

[0035] "Halo" or "halogen" refers to bromo, chloro, fluoro or iodo. In some embodiments, halogen is fluoro or chloro. In some embodiments, halogen is fluoro.

[0036] "Heteroalkyl" refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g., -NH-, -N(alkyl)-), sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C 1 -C 6 heteroalkyl wherein the heteroalkyl is comprised of 1 to 6 carbon atoms and one or more atoms other than carbon, e.g., oxygen, nitrogen (e.g. -NH-, -N(alkyl)-), sulfur, or combinations thereof wherein the heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. Examples of such heteroalkyl are, for example, -CH 2 OCH 3 , - CH 2 CH 2 OCH 3 , -CH 2 CH 2 OCH 2 CH 2 OCH 3 , or -CH(CH 3 )OCH 3 . Unless stated otherwise specifically in the specification, a heteroalkyl is optionally substituted for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, - CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.

[0037] "Hydroxyalkyl" refers to an alkyl radical, as defined above, that is substituted by one or more hydroxyls. In some embodiments, the alkyl is substituted with one hydroxyl. In some embodiments, the alkyl is substituted with one, two, or three hydroxyls. Hydroxyalkyl include, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, or hydroxypentyl. In some embodiments, the hydroxyalkyl is hydroxymethyl.

[0038] "Heterocycloalkyl" refers to a stable 3- to 24-membered partially or fully saturated ring radical comprising 2 to 23 carbon atoms and from one to 8 heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous and sulfur. In some embodiments, the heterocycloalkyl comprises 1 or 2 heteroatoms selected from nitrogen and oxygen. Unless stated otherwise specifically in the specification, the heterocycloalkyl radical may be a monocyclic, bicyclic, tricyclic or tetracyclic ring system, which may include fused (when fused with an aryl or a heteroaryl ring, the heterocycloalkyl is bonded through a non-aromatic ring atom) or bridged ring systems; and the nitrogen, carbon or sulfur atoms in the heterocycloalkyl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized. Representative heterocycloalkyls include, but are not limited to, heterocycloalkyls having from two to fifteen carbon atoms (C 2 -C 15 heterocycloalkyl), from two to ten carbon atoms (C 2 -C 10 heterocycloalkyl), from two to eight carbon atoms (C 2 -C 8 heterocycloalkyl), from two to six carbon atoms (C 2 -C 6 heterocycloalkyl), from two to five carbon atoms (C 2 -C 5 heterocycloalkyl), or two to four carbon atoms (C 2 -C 4 heterocycloalkyl). In some embodiments, the heterocycloalkyl is a 3- to 6-membered heterocycloalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered heterocycloalkyl. Examples of such heterocycloalkyl radicals include, but are not limited to, aziridinyl, azetidinyl, dioxolanyl, thienyl[1,3]dithianyl, decahydroisoquinolyl, imidazolinyl, imidazolidinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperazinyl, 2-oxopiperidinyl, 2-oxopyrrolidinyl, oxazolidinyl, piperidinyl, piperazinyl, 4-piperidonyl, pyrrolidinyl, pyrazolidinyl, quinuclidinyl, thiazolidinyl, tetrahydrofuryl, trithianyl, tetrahydropyranyl, thiomorpholinyl, thiamorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxo-thiomorpholinyl, 1,3-dihydroisobenzofuran-1-yl, 3-oxo-1,3-dihydroisobenzofuran-1-yl, methyl-2-oxo-1,3-dioxol-4-yl, and 2-oxo-1,3-dioxol-4-yl. The term heterocycloalkyl also includes all ring forms of the carbohydrates, including but not limited to, the monosaccharides, the disaccharides and the oligosaccharides. It is understood that when referring to the number of carbon atoms in a heterocycloalkyl, the number of carbon atoms in the heterocycloalkyl is not the same as the total number of atoms (including the heteroatoms) that make up the heterocycloalkyl (i.e. skeletal atoms of the heterocycloalkyl ring). Unless stated otherwise specifically in the specification, a heterocycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a heterocycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, - CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, a heterocycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the heterocycloalkyl is optionally substituted with halogen.

[0039] "Heteroalkyl" refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g. -NH-, -N(alkyl)-), sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C 1 -C 6 heteroalkyl. Unless stated otherwise specifically in the specification, a Heteroalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.

[0040] "Heteroaryl" refers to a 5- to 14-membered ring system radical comprising hydrogen atoms, one to thirteen carbon atoms, one to six heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous and sulfur, and at least one aromatic ring. The heteroaryl radical may be a monocyclic, bicyclic, tricyclic or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocycloalkyl ring, the heteroaryl is bonded through an aromatic ring atom) or bridged ring systems; and the nitrogen, carbon or sulfur atoms in the heteroaryl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized. In some embodiments, the heteroaryl is a 5-to 10-membered heteroaryl. In some embodiments, the heteroaryl is a 5- to 6-membered heteroaryl. Examples include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzothiazolyl, benzindolyl, benzodioxolyl, benzofuranyl, benzooxazolyl, benzothiazolyl, benzothiadiazolyl, benzo[b][1,4]dioxepinyl, 1,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzotriazolyl, benzo[4,6]imidazo[1,2-a]pyridinyl, carbazolyl, cinnolinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, naphthyridinyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 1-oxidopyridinyl, 1-oxidopyrimidinyl, 1-oxidopyrazinyl, 1-oxidopyridazinyl, 1-phenyl-1H-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxalinyl, quinolinyl, quinuclidinyl, isoquinolinyl, tetrahydroquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl (i.e., thienyl). Unless stated otherwise specifically in the specification, a heteroaryl is optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, - CF 3 , -OH, -OMe, -NH 2 , or -NO 2 . In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF 3 , -OH, or -OMe. In some embodiments, the heteroaryl is optionally substituted with halogen.

[0041] The terms "treat," "prevent," "ameliorate," and "inhibit," as well as words stemming therefrom, as used herein, do not necessarily imply 100% or complete treatment, prevention, amelioration, or inhibition. Rather, there are varying degrees of treatment, prevention, amelioration, and inhibition of which one of ordinary skill in the art recognizes as having a potential benefit or therapeutic effect. In this respect, the disclosed methods can provide any amount of any level of treatment, prevention, amelioration, or inhibition of the disorder in a mammal. For example, a disorder, including symptoms or conditions thereof, may be reduced by, for example, about 100%, about 90%, about 80%, about 70%, about 60%, about 50%, about 40%, about 30%, about 20%, or about 10%. Furthermore, the treatment, prevention, amelioration, or inhibition provided by the methods disclosed herein can include treatment, prevention, amelioration, or inhibition of one or more conditions or symptoms of the disorder, e.g., cancer or an inflammatory disease. Also, for purposes herein, "treatment," "prevention," "amelioration," or "inhibition" encompass delaying the onset of the disorder, or a symptom or condition thereof.

[0042] The terms "effective amount" or "therapeutically effective amount," as used herein, refer to a sufficient amount of a compound disclosed herein being administered which will relieve to some extent one or more of the symptoms of the disease or condition being treated, e.g., cancer or an inflammatory disease. In some embodiments, the result is a reduction and / or alleviation of the signs, symptoms, or causes of a disease, or any other desired alteration of a biological system. For example, an "effective amount" for therapeutic uses is the amount of the composition comprising a compound disclosed herein required to provide a clinically significant decrease in disease symptoms. In some embodiments, an appropriate "effective" amount in any individual case is determined using techniques, such as a dose escalation study.

[0043] As used herein, the term "TYK2-mediated" disorders, diseases, and / or conditions as used herein means any disease or other deleterious condition in which TYK2 or a mutant thereof is known to play a role. Accordingly, another embodiment relates to treating or lessening the severity of one or more diseases in which TYK2, or a mutant thereof, is known to play a role. Such TYK2-mediated disorders include but are not limited to autoimmune disorders, inflammatory disorders, proliferative disorders, endocrine disorders, neurological disorders and disorders associated with transplantation.Compounds

[0044] Described herein are compounds that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.

[0045] Disclosed herein is a compound of Formula (I), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: Z is a bond, -CR Z< 2 -, or -(CR Z< 2 ) 2 -; each R Z< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloallcyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0046] In some embodiments of a compound of Formula (I), L is a bond. In some embodiments of a compound of Formula (I), L is -C(=O)-.

[0047] In some embodiments of a compound of Formula (1), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (1), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (1), Ring A is heteroaryl optionally substituted with one or more R A< .

[0048] In some embodiments of a compound of Formula (I), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (I), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (I), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (I), each R A< is independently C 1 -C 6 alkyl.

[0049] In some embodiments of a compound of Formula (1), R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (1), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (1), R 4< is -OR b< . In some embodiments of a compound of Formula (1), R 4< is hydrogen.

[0050] In some embodiments of a compound of Formula (1), the compound is of Formula (Ia):

[0051] In some embodiments of a compound of Formula (1), the compound is of Formula (Ib):

[0052] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (1), (1a), or (Ib), R 3< is hydrogen.

[0053] In some embodiments of a compound of Formula (1), (Ia), or (Ib), Z is a bond or -CH 2 -. In some embodiments of a compound of Formula (1), (Ia), or (Ib), Z is -CH 2 -. In some embodiments of a compound of Formula (1), (Ia), or (Ib), Z is a bond.

[0054] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R' and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (I), (1a), or (Ib), R 1< is hydrogen. In some embodiments of a compound of Formula (1), (1a), or (Ib), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (1), (1a), or (Ib), R 2< is C 1 -C 6 deuteroalkyl.

[0055] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 5< is halogen, -CN, -OR 8< , - NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0056] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 5< is -OR 8< , -NR 9< R 10< , - C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0057] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0058] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (I), (1a), or (Ib), R 5< is -NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0059] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (1), (1a), or (Ib), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (I), (Ia), or (Ib), R 7< is unsubstituted cycloalkyl.

[0060] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0061] In some embodiments of a compound of Formula (1), (Ia), or (Ib), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (I), (1a), or (Ib), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, - C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0062] Also disclosed herein is a compound of Formula (11) or (II'), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: R 11< is deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , -NHS(=O) 2 R a< , - S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , - NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R", -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more RA. each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR B< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl, R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0063] In some embodiments of a compound of Formula (II) or (II'), L is a bond. In some embodiments of a compound of Formula (II) or (II'), L is -C(=O)-.

[0064] In some embodiments of a compound of Formula (II) or (II'), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (II) or (II'), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (11) or (II'), Ring A is heteroaryl optionally substituted with one or more R A< .

[0065] In some embodiments of a compound of Formula (11) or (II'), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II) or (II'), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II) or (II'), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (II) or (II'), each R A< is independently C 1 -C 6 alkyl.

[0066] In some embodiments of a compound of Formula (II) or (II'), R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II) or (II'), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (II) or (II'), R 4< is -OR b< . In some embodiments of a compound of Formula (II) or (II'), R 4< is hydrogen.

[0067] In some embodiments of a compound of Formula (II) or (II'), X is -CH-. In some embodiments of a compound of Formula (II) or (II'), X is -N-.

[0068] In some embodiments of a compound of Formula (II) or (II'), the compound is of Formula (IIa) or (II'a):

[0069] In some embodiments of a compound of Formula (II) or (II'), the compound is of Formula (IIb) or (II'b):

[0070] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 3< is hydrogen.

[0071] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 1< is hydrogen. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 2< is C 1 -C 6 deuteroalkyl.

[0072] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is halogen, -CN, -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , - NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0073] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0074] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is - OR 8< , -NR 9< R 10< , -NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0075] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is - OR 8< , -NR 9< R 10< , -NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is -NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0076] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 7< is unsubstituted cycloalkyl.

[0077] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0078] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, - OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0079] In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 11< is deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (11), (II'), (IIa), (II'a), (IIb), or (II'b), R 11< is deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 11< is halogen. In some embodiments of a compound of Formula (II), (II'), (IIa), (II'a), (IIb), or (II'b), R 11< is hydrogen.

[0080] Also disclosed herein is a compound of Formula (III), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring B is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; provided that is not each R B< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or two R B< on the same carbon are taken together to form an oxo; or two R B< on adjacent atoms are taken together to form a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more deuterium, oxo, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 haloalkyl; n is 0-4; each Y is independently C or N; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more RA. each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0081] In some embodiments of a compound of Formula (III), L is a bond. In some embodiments of a compound of Formula (III), L is -C(=O)-.

[0082] In some embodiments of a compound of Formula (III), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (III), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (III), Ring A is heteroaryl optionally substituted with one or more R A< .

[0083] In some embodiments of a compound of Formula (III), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (III), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (III), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (III), each R A< is independently C 1 -C 6 alkyl.

[0084] In some embodiments of a compound of Formula (III), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (III), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (III), R 4< is -OR b< . In some embodiments of a compound of Formula (III), R 4< is hydrogen.

[0085] In some embodiments of a compound of Formula (III), X is -CH-. In some embodiments of a compound of Formula (III), X is -N-.

[0086] In some embodiments of a compound of Formula (III), the compound is of Formula (IIIa):

[0087] In some embodiments of a compound of Formula (III), the compound is of Formula (IIIb):

[0088] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 3< is hydrogen.

[0089] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is halogen, -CN, - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0090] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is -OR 8< , -NR 9< R 10< , - C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0091] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0092] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0093] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 7< is unsubstituted cycloalkyl.

[0094] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0095] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0096] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), Ring B is a heterocycloalkyl or heteroaryl.

[0097] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), is and n' is 0-3.

[0098] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), each R B< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; or two R B< on the same carbon are taken together to form an oxo. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), each R B< is independently hydrogen, deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; two R B< on the same carbon are taken together to form an oxo.

[0099] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), two R B< on adjacent atoms are taken together to form a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more deuterium, oxo, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), two R B< on adjacent atoms are taken together to form a heterocycloalkyl or heteroaryl; each optionally substituted with one or more deuterium, oxo, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 haloalkyl.

[0100] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 0. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 1. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 2. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 0-2. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 0 or 1. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 1 or 2. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n is 1-3.

[0101] In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 0. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 1. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 2. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 0-2. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 0 or 1. In some embodiments of a compound of Formula (III), (IIIa), or (IIIb), n' is 1 or 2.

[0102] Also disclosed herein is a compound of Formula (IV), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring C is a bicyclic ring system; each R C< is independently hydrogen, oxo, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , - NO 2 , -NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; m is 0-4; R 12< is -C(=O)NR 1< R 2< or -L 1< -R 13< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; L 1< is -O-, -NH-, or -N(CH 3 )-; R 13< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0103] In some embodiments of a compound of Formula (IV), L is a bond. In some embodiments of a compound of Formula (IV), L is -C(=O)-.

[0104] In some embodiments of a compound of Formula (IV), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (IV), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (IV), Ring A is heteroaryl optionally substituted with one or more R A< .

[0105] In some embodiments of a compound of Formula (IV), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (IV), each R A< is independently C 1 -C 6 alkyl.

[0106] In some embodiments of a compound of Formula (IV), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (IV), R 4< is -OR b< . In some embodiments of a compound of Formula (IV), R 4< is hydrogen.

[0107] In some embodiments of a compound of Formula (IV), X is -CH-. In some embodiments of a compound of Formula (IV), X is -N-.

[0108] In some embodiments of a compound of Formula (IV), the compound is of Formula (IVa):

[0109] In some embodiments of a compound of Formula (IV), the compound is of Formula (IVb):

[0110] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 12< is -C(=O)NR 1< R 2< .

[0111] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 1< is hydrogen. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 2< is C 1 -C 6 deuteroalkyl.

[0112] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 12< is -L 1< -R 13< .

[0113] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), L 1< is -NH-. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), L 1< is -O- or -NH-.

[0114] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 13< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0115] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is halogen, -CN, - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0116] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is -OR 8< , -NR 9< R 10< , - C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0117] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0118] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0119] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 7< is unsubstituted cycloalkyl.

[0120] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0121] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0122] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), Ring C is indole or benzimidazole.

[0123] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), each R C< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0124] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), each R C< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), each R C< is independently halogen or C 1 -C 6 alkyl.

[0125] In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 0. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 1. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 2. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 0 or 1. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 0-2. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 1 or 2. In some embodiments of a compound of Formula (IV), (IVa), or (IVb), m is 1-3.

[0126] Also disclosed herein is a compound of Formula (V), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; or two R D< on adjacent atoms are taken together to form a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more deuterium, oxo, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 haloalkyl; r is 0-4; each Y is independently C or N; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0127] In some embodiments of a compound of Formula (V), L is a bond. In some embodiments of a compound of Formula (V), L is -C(=O)-.

[0128] In some embodiments of a compound of Formula (V), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (V), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (V), Ring A is heteroaryl optionally substituted with one or more R A< .

[0129] In some embodiments of a compound of Formula (V), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (V), each R A< is independently C 1 -C 6 alkyl.

[0130] In some embodiments of a compound of Formula (V), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (V), R 4< is -OR b< . In some embodiments of a compound of Formula (V), R 4< is hydrogen.

[0131] In some embodiments of a compound of Formula (V), each X is -N-. In some embodiments of a compound of Formula (V), each X is -CH-. In some embodiments of a compound of Formula (V), one X is -N- and the other is -CH-.

[0132] In some embodiments of a compound of Formula (V), the compound is of Formula (Va):

[0133] In some embodiments of a compound of Formula (V), the compound is of Formula (Vb):

[0134] In some embodiments of a compound of Formula (V), (Va), or (Vb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), R 3< is hydrogen.

[0135] In some embodiments of a compound of Formula (V), (Va), or (Vb), R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), R 1< is hydrogen. In some embodiments of a compound of Formula (V), (Va), or (Vb), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), R 2< is C 1 -C 6 deuteroalkyl.

[0136] In some embodiments of a compound of Formula (V), (Va), or (Vb), Ring D is a heterocycloalkyl or heteroaryl.

[0137] In some embodiments of a compound of Formula (V), (Va), or (Vb), is and r' is 0-3.

[0138] In some embodiments of a compound of Formula (V), (Va), or (Vb), each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, or heterocycloalkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), each R D< is independently hydrogen, deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl. In some embodiments of a compound of Formula (V), (Va), or (Vb), each R D< is independently hydrogen or cycloalkyl.

[0139] In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 0. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 1. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 0-2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 0 or 1. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 1 or 2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r is 1-3.

[0140] In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 0. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 1. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 0-2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 0 or 1. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 1 or 2. In some embodiments of a compound of Formula (V), (Va), or (Vb), r' is 1-3.

[0141] Also disclosed herein is a compound of Formula (VI), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring E is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R E< ; each R E< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R E< on the same carbon are taken together to form an oxo; L 2< is a bond, -O-, or ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl, each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0142] In some embodiments of a compound of Formula (VI), L is a bond. In some embodiments of a compound of Formula (VI), L is -C(=O)-.

[0143] In some embodiments of a compound of Formula (VI), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VI), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VI), Ring A is heteroaryl optionally substituted with one or more R A< .

[0144] In some embodiments of a compound of Formula (VI), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VI), each R A< is independently C 1 -C 6 alkyl.

[0145] In some embodiments of a compound of Formula (VI), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (VI), R 4< is -OR b< . In some embodiments of a compound of Formula (VI), R 4< is hydrogen.

[0146] In some embodiments of a compound of Formula (VI), X is -CH-. In some embodiments of a compound of Formula (VI), X is -N-.

[0147] In some embodiments of a compound of Formula (VI), the compound is of Formula (VIa):

[0148] In some embodiments of a compound of Formula (VI), the compound is of Formula (VIb):

[0149] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 3< is hydrogen.

[0150] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 1< is hydrogen. In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VI), (VIa), or (VIb), R 2< is C 1 -C 6 deuteroalkyl.

[0151] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), L 2< is a bond.

[0152] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), Ring E is cycloalkyl, heterocycloalkyl, or aryl; each optionally substituted with one or more R E< .

[0153] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), Ring E is aryl optionally substituted with one or more R E< .

[0154] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), each R E< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0155] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), each R E< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0156] In some embodiments of a compound of Formula (VI), (VIa), or (VIb), each R E< is independently halogen.

[0157] Also disclosed herein is a compound of Formula (VII), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: R 14< is hydrogen, -S(=O)R a< , -S(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), C 1 -C 6 alkyl(heteroaryl), cycloalkyl, or heterocycloalkyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0158] In some embodiments of a compound of Formula (VII), L is a bond. In some embodiments of a compound of Formula (VII), L is -C(=O)-.

[0159] In some embodiments of a compound of Formula (VII), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VII), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VII), Ring A is heteroaryl optionally substituted with one or more R A< .

[0160] In some embodiments of a compound of Formula (VII), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VII), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VII), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VII), each R A< is independently C 1 -C 6 alkyl.

[0161] In some embodiments of a compound of Formula (VII), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VII), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (VII), R 4< is -OR b< . In some embodiments of a compound of Formula (VII), R 4< is hydrogen.

[0162] In some embodiments of a compound of Formula (VII), X is -CH-. In some embodiments of a compound of Formula (VII), X is -N-.

[0163] In some embodiments of a compound of Formula (VII), the compound is of Formula (VIIa):

[0164] In some embodiments of a compound of Formula (VII), the compound is of Formula (VIIb):

[0165] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 3< is hydrogen.

[0166] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is halogen, -CN, - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0167] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0168] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is -OR 8< , -NR 9< R 10< , -NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0169] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is -OR 8< , -NR 9< R 10< , -NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0170] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 7< is unsubstituted cycloalkyl.

[0171] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0172] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0173] In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 14< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 alkyl(cycloalkyl). In some embodiments of a compound of Formula (VII), (VIIa), or (VIIb), R 14< is C 1 -C 6 alkyl or C 1 -C 6 alkyl(cycloalkyl).

[0174] Also disclosed herein is a compound of Formula (VIII), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: R 15< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; L 3< is -O-, -NH-, or -N(CH 3 )-; L 4< is -NR 3< - or -C(=O)-; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(-O)NR c< R d< . -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0175] In some embodiments of a compound of Formula (VIII), L is a bond. In some embodiments of a compound of Formula (VIII), L is -C(=O)-.

[0176] In some embodiments of a compound of Formula (VIII), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VIII), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (VIII), Ring A is heteroaryl optionally substituted with one or more R A< .

[0177] In some embodiments of a compound of Formula (VIII), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VIII), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VIII), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VIII), each R A< is independently C 1 -C 6 alkyl.

[0178] In some embodiments of a compound of Formula (VIII), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (VIII), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (VIII), R 4< is -OR b< . In some embodiments of a compound of Formula (VIII), R 4< is hydrogen.

[0179] In some embodiments of a compound of Formula (VIII), X is -CH-. In some embodiments of a compound of Formula (VIII), X is -N-.

[0180] In some embodiments of a compound of Formula (VIII), the compound is of Formula (VIIIa):

[0181] In some embodiments of a compound of Formula (VIII), the compound is of Formula (VIIIb):

[0182] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 5< is halogen, - CN, -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0183] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 5< is -OR 8< , - NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0184] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 5< is -OR 8< , - NR 9< R 10< , -NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, - OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0185] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 5< is -OR 8< , - NR 9< R 10< , -NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0186] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, - C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), R 7< is unsubstituted cycloalkyl.

[0187] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0188] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0189] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), L 3< is -0-. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), L 3< is -NH-.

[0190] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 15< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl.

[0191] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), L 4< is -NR 3< -.

[0192] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (VIII), (VIIIa), or (VIIIb), R 3< is hydrogen.

[0193] In some embodiments of a compound of Formula (VIII), (Villa), or (VIIIb), L 4< is -C(=O)-.

[0194] A compound of Formula (IX), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring F is a heterocycloalkyl or heteroaryl; each R F< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or two R F< on the same carbon are taken together to form an oxo; or two R F< on adjacent atoms are taken together to form a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more deuterium, oxo, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or C 1 -C 6 haloalkyl; p is 0-4; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , - C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0195] In some embodiments of a compound of Formula (IX), L is a bond. In some embodiments of a compound of Formula (IX), L is -C(=O)-.

[0196] In some embodiments of a compound of Formula (IX), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (IX), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (IX), Ring A is heteroaryl optionally substituted with one or more R A< .

[0197] In some embodiments of a compound of Formula (IX), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IX), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IX), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (IX), each R A< is independently C 1 -C 6 alkyl.

[0198] In some embodiments of a compound of Formula (IX), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IX), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (IX), R 4< is -OR b< . In some embodiments of a compound of Formula (IX), R 4< is hydrogen.

[0199] In some embodiments of a compound of Formula (IX), X is -CH-. In some embodiments of a compound of Formula (IX), X is -N-.

[0200] In some embodiments of a compound of Formula (IX), the compound is of Formula (IXa):

[0201] In some embodiments of a compound of Formula (IX), the compound is of Formula (IXb):

[0202] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 3< is hydrogen.

[0203] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is halogen, -CN, - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0204] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is -OR 8< , -NR 9< R 10< , - C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0205] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0206] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0207] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 7< is unsubstituted cycloalkyl.

[0208] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0209] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0210] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), Ring F is a heterocycloalkyl.

[0211] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), is

[0212] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), each R F< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), each R F< is independently hydrogen, deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0213] In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 0. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 1. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 2. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 0-2. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 0 or 1. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 1 or 2. In some embodiments of a compound of Formula (IX), (IXa), or (IXb), p is 1-3.

[0214] Also disclosed herein is a compound of Formula (X), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof wherein: L 5< is a saturated or unsaturated linear aliphatic chain having 1-10 carbon atoms optionally substituted with one or more R L5< , wherein 1-5 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, - S-, -S(=O)-, -S(=O) 2 -, or -P(=O)-; each R L5< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or two R L5< on the same carbon atom are taken together to form an oxo; R 12< is -C(=O)NR 1< R 2< or -L 1< -R 13< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; L 1< is -O-, -NH-, or -N(CH 3 )-; R 13< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0215] In some embodiments of a compound of Formula (X), L is a bond. In some embodiments of a compound of Formula (X), L is -C(=O)-.

[0216] In some embodiments of a compound of Formula (X), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (X), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (X), Ring A is heteroaryl optionally substituted with one or more R A< .

[0217] In some embodiments of a compound of Formula (X), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (X), each R A< is independently C 1 -C 6 alkyl.

[0218] In some embodiments of a compound of Formula (X), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (X), R 4< is -OR b< . In some embodiments of a compound of Formula (X), R 4< is hydrogen.

[0219] In some embodiments of a compound of Formula (X), X is -CH-. In some embodiments of a compound of Formula (X), X is -N-.

[0220] In some embodiments of a compound of Formula (X), the compound is of Formula In some embodiments of a compound of Formula (X), the compound is of Formula

[0221] In some embodiments of a compound of Formula (X), the compound is of Formula (Xa):

[0222] In some embodiments of a compound of Formula (X), the compound is of Formula (Xb):

[0223] In some embodiments of a compound of Formula (X), the compound is of Formula (Xa-1):

[0224] In some embodiments of a compound of Formula (X), the compound is of Formula (Xb-1):

[0225] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 3< is hydrogen.

[0226] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 12< is - C(=O)NR 1< R 2< .

[0227] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 1< is hydrogen. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 2< is C 1 -C 6 deuteroalkyl.

[0228] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 12< is -L 1< -R13.

[0229] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 1< is - NH-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 1< is -O- or - NH-.

[0230] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), R 13< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl.

[0231] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, -S(=O) 2 -, or -P(=O)-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -O-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0232] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, or -S(=O) 2 -. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -0-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with - NH- or -O-.

[0233] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, or - S(=O) 2 -. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -O-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L5< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0234] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, -S(=O) 2 -, or -P(=O)-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -O-. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0235] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), each R L5< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), each R L5< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), each R L5< is independently deuterium or halogen.

[0236] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), two R L5< on the same carbon atom are taken together to form an oxo.

[0237] In some embodiments of a compound of Formula (X), (Xa), (Xa-1), (Xb), or (Xb-1), L 5< is

[0238] Also disclosed herein is a compound of Formula (XI), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: L 6< is a saturated or unsaturated linear aliphatic chain having 1-10 carbon atoms optionally substituted with one or more R L6< , wherein 1-5carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, - S-, -S(=O)-,-S(=O) 2 -, or -P(=O)-; each R L6< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or two R L6< on the same carbon atom are taken together to form an oxo; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; X is -CR x< - or -N-; R x< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is hydrogen, halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=O)R 7< , -OC(=O)R 7< , -C(=O)OR 8< , -OC(=O)OR 8< , -C(=O)NR 9< R 10< , -OC(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR B< C(=O)OR B< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0239] In some embodiments of a compound of Formula (XI), L is a bond. In some embodiments of a compound of Formula (XI), L is -C(=O)-.

[0240] In some embodiments of a compound of Formula (XI), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (XI), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (XI), Ring A is heteroaryl optionally substituted with one or more R A< .

[0241] In some embodiments of a compound of Formula (XI), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XI), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XI), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XI), each R A< is independently C 1 -C 6 alkyl.

[0242] In some embodiments of a compound of Formula (XI), R 4< is hydrogen, deuterium, halogen, - CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XI), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (XI), R 4< is -OR b< . In some embodiments of a compound of Formula (XI), R 4< is hydrogen.

[0243] In some embodiments of a compound of Formula (XI), X is -CH-. In some embodiments of a compound of Formula (XI), X is -N-.

[0244] In some embodiments of a compound of Formula (XI), the compound is of Formula (XIa):

[0245] In some embodiments of a compound of Formula (XI), the compound is of Formula (XIb):

[0246] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 3< is hydrogen.

[0247] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is halogen, -CN, - OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< . C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0248] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is -OR 8< , -NR 9< R 10< , - C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , - C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0249] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , or aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , - NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0250] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is -OR 8< , -NR 9< R 10< , - NR 8< C(=O)R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is - NR 8< C(=O)R 7< . In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0251] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 7< is cycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 7< is unsubstituted cycloalkyl.

[0252] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 8< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0253] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C b haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, - C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0254] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, or -S(=O) 2 -. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -0-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0255] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with - NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, or -S(=O) 2 -. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -0-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is a saturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0256] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, -S(=O) 2 -, or -P(=O)-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -O-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms optionally substituted with one or more R L6< , wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -O-.

[0257] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, -O-, -S-, -S(=O)-, -S(=O) 2 -, or -P(=O)-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH-, -N(CH 3 )-, or -O-. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is an unsaturated linear aliphatic chain having 1-8 carbon atoms, wherein 1, 2, or 3 carbon atoms are optionally replaced with -NH- or -0-.

[0258] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), each R L6< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), each R L6< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XI), (XIa), or (XIb), each R L6< is independently deuterium or halogen.

[0259] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), two R L6< on the same carbon atom are taken together to form an oxo.

[0260] In some embodiments of a compound of Formula (XI), (XIa), or (XIb), L 6< is

[0261] Also disclosed herein is a compound of Formula (XII), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; or -L-Ring A is absent; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR B< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=O)R 7< , -NR B< C(=N-CN)OR B< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, orC 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 1 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0262] Also disclosed herein is a compound of Formula (XII), or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; or -L-Ring A is absent; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(= O< )R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR°R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 C 6 alkyl, or C 1 -C 6 haloalkyl; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0263] Also disclosed herein is a compound of Formula (XII), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more RA. each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=O)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0264] Also disclosed herein is a compound of Formula (XII), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: Ring B is cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=O)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0265] In some embodiments of a compound of Formula (XII), Ring B is aryl or heteroaryl. In some embodiments of a compound of Formula (XII), Ring B is aryl. In some embodiments of a compound of Formula (XII), Ring B is phenyl. In some embodiments of a compound of Formula (XII), Ring B is heteroaryl. In some embodiments of a compound of Formula (XII), Ring B is 5- or 6-membered heteroaryl. In some embodiments of a compound of Formula (XII), Ring B is 6-membered heteroaryl. In some embodiments of a compound of Formula (XII), Ring B is pyridyl.

[0266] Also disclosed herein is a compound of Formula (XII'), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof: wherein: R 16< is -C(=O)NR 1< R 2< , -C(=N-CN)NR 1< R 2< , -P(=O)R 1< R 2< , or -C(=O)R 11< ; R 1< and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 3< is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl; R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , -P(=O)R b< R b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; or R 3< and R 4< are taken together to form an optionally substituted ring; L is a bond or -C(=O)-; Ring A is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each optionally substituted with one or more R A< ; each R A< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R A< on the same carbon are taken together to form an oxo; each X is independently -CR x< - or -N-; each R x< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NR 8< S(=O)R 7< , -NR 8< S(=O) 2 R 7< , - S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , -C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , - OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=O)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R x< and R 5< are taken together to form ring D optionally substituted with one or more R D< ; Ring D is a cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; each R D< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , - NR c< R d< , -NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , - C(=O)NR c< R d< , -OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or two R D< on the same carbon are taken together to form an oxo; R 7< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R 8< is independently hydrogen, CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 9< and R 10< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 hydroxydeuteroalkyl, cycloalkyl, or heterocycloalkyl; or R 9< and R 10< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R 8< and R 9< are taken together with the atoms to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , - C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< ; each R 11a< is independently deuterium, halogen, -CN, -OR b< , -SR b< , -S(=O)R a< , -S(=O) 2 R a< , -NO 2 , -NR c< R d< , - NHS(=O) 2 R a< , -S(=O) 2 NR c< R d< , -C(=O)R a< , -OC(=O)R a< , -C(=O)OR b< , -OC(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , -NR b< C(=O)NR c< R d< , -NR b< C(=O)R a< , -NR b< C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl; each R a< is independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R b< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, - NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; each R c< and R d< is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl; or R c< and R d< are taken together with the nitrogen atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OH, -OMe, -NH 2 , -C(=O)Me, -C(=O)OH, -C(=O)OMe, C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0267] In some embodiments of a compound of Formula (XII) or (XII'), L is a bond. In some embodiments of a compound of Formula (XII) or (XII'), L is -C(=O)-.

[0268] In some embodiments of a compound of Formula (XII) or (XII'), -L-Ring A is absent.

[0269] In some embodiments of a compound of Formula (XII) or (XII'), Ring A is heterocycloalkyl or heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (XII) or (XII'), Ring A is a 5-membered heterocycloalkyl or a 5-membered heteroaryl; each optionally substituted with one or more R A< . In some embodiments of a compound of Formula (XII) or (XII'), Ring A is heteroaryl optionally substituted with one or more R A< .

[0270] In some embodiments of a compound of Formula (XII) or (XII'), each R A< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , -OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII) or (XII'), each R A< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII) or (XII'), each R A< is independently halogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XII) or (XII'), each R A< is independently C 1 -C 6 alkyl.

[0271] In some embodiments of a compound of Formula (XII), the compound is of Formula (XIIa):

[0272] In some embodiments of a compound of Formula (XII), the compound is of Formula (XIIb):

[0273] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 4< is hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , - OC(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 4< is hydrogen or -OR b< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 4< is -OR b< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 4< is hydrogen. In some embodiments of a compound of Formula (XII), R 4< is -P(=O)R b< R b< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 4< is -S(=O) 2 R a< .

[0274] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each X is -N-. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc) each X is -CR X< -. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), two X are -N- and the other is -CR X< -. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), one X is -N- and the others are -CR X< -. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each X is -CH-. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), two X are -N- and the other is -CH-. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), one X is -N- and the others are -CH-. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is

[0275] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R X< is independently hydrogen, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, or C 1 -C 6 aminoalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R X< is independently hydrogen, deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R X< is independently hydrogen, deuterium, or halogen.

[0276] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), is

[0277] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 3< is hydrogen or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 3< is hydrogen.

[0278] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 16< is -C(=O)NR 1< R 2< or -C(=O)R 11< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 16< is -C(=O)NR 1< R 2< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 16< is -C(=N-CN)NR 1< R 2< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 16< is -P(=O)R 1< R 2< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 16< is -C(=O)R 11< .

[0279] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R' and R 2< are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 1< and R 2< are independently hydrogen or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 1< and R 2< are independently C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 1< is hydrogen. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 2< is C 1 -C 6 alkyl or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 2< is C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 2< is C 1 -C 6 alkyl.

[0280] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R 11a< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, cycloalkyl, or heterocycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R 11a< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, cycloalkyl, or heterocycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R 11a< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or cycloalkyl; wherein each alkyl and cycloalkyl is independently optionally substituted with one or more R 11a< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl or cycloalkyl; wherein each alkyl and cycloalkyl is independently optionally substituted with one or more R 11a< . In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 haloalkyl, or cycloalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or cycloalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is cycloalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), R 11< is C 1 -C 6 alkyl, C 1 -C 6 deuteroalkyl, or cycloalkyl.

[0281] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, or C 1 -C 6 aminoalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, or C 1 -C 6 aminoalkyl. In some embodiments of a compound of Formula (XII), (XII'),

[0282] (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, -CN, -OR b< , -NR c< R d< , or C 1 -C 6 alkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, or C 1 -C 6 deuteroalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), (XIIb), or (XIIc), each R 11a< is independently deuterium, halogen, or C 1 -C 6 alkyl.

[0283] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is halogen, -CN, -OR 8< , -SR 8< , -S(=O)R 7< , -S(=O) 2 R 7< , -NO 2 , -NR 9< R 10< , -NHS(=O) 2 R 7< , -S(=O) 2 NR 9< R 10< , -C(=N-CN)R 7< ,-C(=O)R 7< , -OC(=N-CN)R 7< , -OC(=O)R 7< , -C(=N-CN)OR 8< , -C(=O)OR 8< , -OC(=N-CN)OR 8< , -OC(=O)OR 8< , - C(=N-CN)NR 9< R 10< , -C(=O)NR 9< R 10< , -OC(=N-CN)NR 9< R 10< , -OC(=O)NR 9< R 10< , -NR 8< C(=N-CN)NR 9< R 10< , - NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=N-OH)R 7< , -NR 8< C(=N-CN)OR 8< , -NR 8< C(=O)OR 8< , - NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , - C(=O)NR c< R d< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 1 -C 6 heteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C 1 -C 6 alkyl(cycloalkyl), C 1 -C 6 alkyl(heterocycloalkyl), C 1 -C 6 alkyl(aryl), or C 1 -C 6 alkyl(heteroaryl); wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, orC 1 -C 6 haloalkyl.

[0284] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is halogen, -CN, -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , - NR 8< C(=O)R 7< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0285] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is halogen, -CN, -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , - NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0286] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is halogen, -CN, -OR 8< , -NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , - NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 deuteroalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0287] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is -OR 8< , - NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=O)R 7< , - NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0288] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is -OR 8< , - NR 9< R 10< , -C(=O)R 7< , -C(=O)OR 8< , -C(=O)NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< C(=O)OR 8< , -NR 8< S(=O)(=NR 8< )R 7< , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is - OR 8< , -NR 9< R 10< , -NR 8< C(=O)R 7< , -NR 8< C(=N-CN)R 7< , -NR 8< S(=O)(=NR 8< )R 7< , or aryl optionally substituted with one or more deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0289] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is -OR 8< , - NR 9< R 10< , -NR 8< C(=N-CN)R 7< , -NR 8< S(=O)(=NR 8< )R 7< , or aryl optionally substituted with one or more deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0290] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is -OR 8< , - NR 9< R 10< , -NR C(=O)R , cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; wherein each cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , -C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl. In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is aryl optionally substituted with one or more oxo, deuterium, halogen, -CN, -OR b< , -NR c< R d< , -C(=O)R a< , - C(=O)OR b< , -C(=O)NR c< R d< , C 1 -C 6 alkyl, or C 1 -C 6 haloalkyl.

[0291] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is - NR 9< R 10< , -NR 8< C(=O)NR 9< R 10< , or -NR 8< C(=N-CN)R 7< .

[0292] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is - NR 9< R 10< .

[0293] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is -NR 9< R 10< or -NR 8< C(=O)NR 9< R 10< .

[0294] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is - NR 8< C(=N-CN)R 7< .

[0295] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5< is - NR 8< S(=O)(=NR 8< )R 7< .

[0296] In some embodiments of a compound of Formula (XII), (XII'), (XIIa), or (XIIb), R 5...

Claims

1. A compound: or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof.

2. The compound of claim 1, wherein said pharmaceutically acceptable salt is prepared by reaction of the compound with a mineral, organic acid, or inorganic base.

3. The compound of claim 1 or 2, wherein said pharmaceutically acceptable salt is selected from the group consisting of acetate, acrylate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate, bisulfite, bromide, butyrate, butyn-1,4-dioate, camphorate, camphorsulfonate, caproate, caprylate, chlorobenzoate, chloride, citrate, cyclopentanepropionate, decanoate, digluconate, dihydrogenphosphate, dinitrobenzoate, dodecylsulfate, ethane sulfonate, formate, fumarate, glucoheptanoate, glycerophosphate, glycolate, hemisulfate, heptanoate, hexanoate, hexyne-1,6-dioate, hydroxybenzoate, γ-hydroxybutyrate, hydrochloride, hydrobromide, hydroiodide, 2-hydroxyethanesulfonate, iodide, isobutyrate, lactate, maleate, malonate, methanesulfonate, mandelate metaphosphate, methane sulfonate, methoxybenzoate, methylbenzoate, monohydrogenphosphate, 1-napthalenesulfonate, 2-napthalenesulfonate, nicotinate, nitrate, palmoate, pectinate, persulfate, 3-phenylpropionate, phosphate, picrate, pivalate, propionate, pyrosulfate, pyrophosphate, propiolate, phthalate, phenylacetate, phenylbutyrate, propanesulfonate, salicylate, succinate, sulfate, sulfite, succinate, suberate, sebacate, sulfonate, tartrate, thiocyanate, tosylateundeconate, and xylenesulfonate.

4. The compound of claim 1 or 2, wherein said pharmaceutically acceptable salt is formed by reacting the free base form of the compound with a pharmaceutically acceptable inorganic or organic acid selected from hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, metaphosphoric acid, acetic acid, propionic acid, hexanoic acid, cyclopentanepropionic acid, glycolic acid, pyruvic acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, p-toluenesulfonic acid, tartaric acid, trifluoroacetic acid, citric acid, benzoic acid, 3-(4-hydroxybenzoyl)benzoic acid, cinnamic acid, mandelic acid, arylsulfonic acid, methanesulfonic acid, ethanesulfonic acid, 1,2-ethanedisulfonic acid, 2-hydroxyethanesulfonic acid, benzene sulfonic acid, 2-naphthalene sulfonic acid, 4-methylbicyclo-[2.22]oct-2-ene-1-carboxylic acid, glucoheptonic acid, 4,4'-methylenebis-(3-hydroxy-2-ene-1-carboxylic acid), 3-phenylpropionic acid, trimethylacetic acid, tertiary butylacetic acid, lauryl sulfuric acid, gluconic acid, glutamic acid, hydroxynaphthoic acid, salicylic acid, stearic acid, and muconic acid.

5. The compound of claim 1, wherein the compound is:

6. A hydrochloride salt of the compound defined in claim 1.

7. A pharmaceutical composition comprising the compound of any one of claims 1 to 5, or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof, or the hydrochloride salt of claim 6, and a pharmaceutically acceptable excipient.

8. The pharmaceutical composition of claim 7, wherein the pharmaceutically composition is formulated for oral, topical, rectal, vaginal, transdermal, parenteral, intrapulmonary, intradermal, intrathecal, epidural and / or intranasal administration.

9. The compound of any one of claims 1 to 5, the hydrochloride salt of claim 6, or the pharmaceutical composition of claim 7 or claim 8, for use in therapy.

10. A compound:

11. A compound:

12. The compound of claim 1, prepared by a process comprising the steps of: a) reducing the compound of claim 10 to provide the compound of claim 11; and b) coupling the compound of claim 11 with a compound: to provide the compound of claim 1.